Drug Shortage Report for RELPAX

Last updated on 2019-12-20 History
Report ID 90386
Drug Identification Number 02256304
Brand name RELPAX
Common or Proper name Relpax
Company Name BGP PHARMA ULC
Market Status MARKETED
Active Ingredient(s) ELETRIPTAN
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 6's
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-07-31
Estimated end date
Actual end date 2019-12-19
Shortage status Resolved
Updated date 2019-12-20
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-07-31 English Compare
v2 2019-07-31 English Compare
v3 2019-07-31 French Compare
v4 2019-08-01 English Compare
v5 2019-12-04 English Compare
v6 2019-12-04 French Compare
v7 2019-12-18 English Compare
v8 2019-12-18 French Compare
v9 2019-12-20 English Compare
v10 2019-12-20 French Compare

Showing 1 to 10 of 10